THRD Insider Trading Activity and SEC Form 4 Filings
THRD insider trading summary
No open-market insider purchases or sales of Third Harmonic Bio, Inc. (THRD) have been reported on SEC Form 4 in the past 12 months.
Latest THRD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 8, 2024 | Edward R. Conner | Chief Medical Officer | Sell | $32K (2,117 @ $15.00) |
| Oct 29, 2024 | Bvf I Gp LLC | Insider | Sell | $7.7M (538,420 @ $14.30) |
| Oct 29, 2024 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $5.7M (396,963 @ $14.30) |
| Oct 29, 2024 | Bvf Inc/Il | Insider | Sell | $5.7M (396,963 @ $14.30) |
| Oct 29, 2024 | Bvf Partners L P/Il | Insider | Sell | $5.7M (396,963 @ $14.30) |
| Oct 29, 2024 | Biotechnology Value Fund II LP | Insider | Sell | $7.7M (538,420 @ $14.30) |
| Oct 29, 2024 | Bvf Partners L P/Il | Insider | Sell | $7.7M (538,420 @ $14.30) |
| Oct 29, 2024 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $924K (64,617 @ $14.30) |
| Oct 29, 2024 | Biotechnology Value Fund L P | Insider | Sell | $7.7M (538,420 @ $14.30) |
| Oct 29, 2024 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $7.7M (538,420 @ $14.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.